News

Gladstone in the News May 3, 2023

Should I Bother Getting a Bivalent COVID Booster Now?

San Francisco Chronicle—Gladstone Senior Investigator Nadia Roan explains that while prior vaccination or exposure to COVID-19 may confer long-term protection against serious disease, a booster shot with the bivalent vaccine will protect you for a few months against new infection.

Gladstone Experts COVID-19 Virology Roan Lab

Article December 16, 2022

Tips from Virologists to Face the “Tripledemic” This Holiday Season

Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter

Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab

Gladstone in the News December 10, 2022

New COVID Subvariants Are ‘the Most Immune Evasive Yet.’ Here’s What That Means

San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News December 2, 2022

Time to Wear a Mask Again? Here’s What Bay Area Health Experts Say amid Rising COVID Cases

San Francisco Chronicle—Although requirements for mask wearing and social distancing have eased around the country, a third winter of the pandemic is looming. Gladstone Senior Investigator Warner Greene recommends paying attention to local trends in case numbers to decide which COVID-19 precautions to take.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News December 1, 2022

COVID Cases and Hospitalizations Are Surging Again in California. What Will It Mean This Time?

San Francisco Chronicle—In an update to a previous article, Senior Investigator Warner Greene now expects both COVID and flu to spread during the holidays and encourages people in high-risk groups to take extra precautions to avoid infection.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Gladstone in the News November 17, 2022

‟Swarm” of Variants Is Driving up California COVID Cases. Is This the Start of the Next Surge?

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, shares his views on the likelihood of a new COVID surge this winter.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News November 15, 2022

InvisiShield Technologies Announces the Appointment of Warner C. Greene, MD, PhD as President and Chief Scientific Officer

Invisishield Technologies—Gladstone Senior Investigator Warner Greene has been appointed President and Chief Scientific Officer of Invisihield Technologies. Invisishield is focused on developing intranasal preventatives for respiratory viruses, including SARS-CoV-2.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News October 20, 2022

Scientists Explain What We Should Expect as COVID Variants Xbb, Bq.1 Spread in Europe, Asia

ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News October 16, 2022

How Long Does Immunity from the New COVID Bivalent Boosters Last ’in the Real World’?

San Francisco Chronicle—The new bivalent COVID-19 booster shots are recommended for individuals age 5 and up who are at least two months past their last vaccine dose. Gladstone Investigator Nadia Roan explains that the bivalent boosters greatly increase the levels of antibodies that can prevent the Omicron variant from infecting cells.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News September 10, 2022

When’s the Best Time to Get the New COVID Booster Shot? Here’s What Experts Say

San Francisco Chronicle—New COVID-19 booster shots targeting both the ancestral virus and omicron strains are now available. Gladstone Investigator Nadia Roan weighs in on when people should get the jab, based on the timing of their last dose and whether they’ve been recently infected.

Gladstone Experts COVID-19 Virology Roan Lab

Article September 9, 2022

New Antiviral Therapy May Block COVID-19 Transmission

The single-dose, intranasal treatment also reduces symptoms of multiple variants of the SARS-CoV-2 virus

News Release Research (Publication) COVID-19 Center for Cell Circuitry Virology Weinberger Lab Chaturvedi

Gladstone in the News September 1, 2022

CDC Authorizes New Omicron-Specific Booster Shots against COVID

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, says that it makes more sense to boost immunity with the newly approved bivalent vaccines targeting Omicron than with vaccines that aim at long-extinct variants of the coronavirus.

Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab

Article August 23, 2022

Meet Gladstone: Abdullah Syed

Abdullah Syed, who is researching SARS-CoV-2, shares his passion for bad puns and animal facts, as well as his favorite part of working at Gladstone.

Graduate Students and Postdocs Profile COVID-19 Doudna Lab

Gladstone in the News July 26, 2022

Why Federal Government Is Putting Second COVID Boosters ‟On Hold” for People under 50

ABC7 News—The federal government plans to roll out a new vaccine against the BA.5 Omicron variant now predominant in the US early this fall. Senior Investigator Warner Greene, MD, PhD, says that you might want to hold off for your next booster shot until you can get this new vaccine, which will offer better protection against currently circulating variants.

Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab

Gladstone in the News July 25, 2022

Researchers Find SARS-CoV-2 Antibodies Less Effective against Omicron

The Daily Californian—Senior Investigator Melanie Ott, MD, PhD, and collaborator Abdullah Syed, PhD, a postdoctoral fellow in the laboratory of Senior Investigator Jennifer Doudna, explain how they discovered that antibodies against early versions of the SARS-CoV-2 virus do not protect well against the now widespread and highly contagious Omicron variant, and recommend masking to avoid new infections.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab